CTCX logo

Carmell Therapeutics (CTCX) Cash From Operations

Annual CFO

-$8.35 M
-$4.92 M-143.48%

December 31, 2023


Summary


Performance

CTCX Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTCXcash flowmetrics:

Quarterly CFO

-$1.40 M
-$264.10 K-23.20%

September 30, 2024


Summary


Performance

CTCX Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTCXcash flowmetrics:

TTM CFO

-$7.03 M
+$2.58 M+26.84%

September 30, 2024


Summary


Performance

CTCX TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTCXcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CTCX Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-143.5%0.0%0.0%
3 y3 years-609.4%--
5 y5 years-609.4%--

CTCX Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-609.4%at low-619.6%+64.8%-3506.0%+26.8%
5 y5-year-609.4%at low-619.6%+64.8%-3506.0%+26.8%
alltimeall time-609.4%at low-619.6%+64.8%-3506.0%+26.8%

Carmell Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.40 M(+23.2%)
-$7.03 M(-26.8%)
Jun 2024
-
-$1.14 M(+5.8%)
-$9.61 M(+7.4%)
Mar 2024
-
-$1.08 M(-68.5%)
-$8.95 M(+7.2%)
Dec 2023
-$8.35 M
-$3.41 M(-14.3%)
-$8.35 M(+69.1%)
Sep 2023
-
-$3.98 M(+729.0%)
-$4.94 M(+136.7%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$480.20 K(+0.9%)
-$2.09 M(+15.8%)
Mar 2023
-
-$476.00 K(-57.9%)
-$1.80 M(+35.9%)
Dec 2022
-$3.43 M(+191.4%)
-
-
Sep 2022
-
-$1.13 M(+479.5%)
-$1.32 M(+579.5%)
Jun 2022
-
-$194.90 K
-$194.90 K
Dec 2021
-$1.18 M
-
-

FAQ

  • What is Carmell Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Carmell Therapeutics?
  • What is Carmell Therapeutics annual CFO year-on-year change?
  • What is Carmell Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Carmell Therapeutics?
  • What is Carmell Therapeutics quarterly CFO year-on-year change?
  • What is Carmell Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Carmell Therapeutics?
  • What is Carmell Therapeutics TTM CFO year-on-year change?

What is Carmell Therapeutics annual cash flow from operations?

The current annual CFO of CTCX is -$8.35 M

What is the all time high annual CFO for Carmell Therapeutics?

Carmell Therapeutics all-time high annual cash flow from operations is -$1.18 M

What is Carmell Therapeutics annual CFO year-on-year change?

Over the past year, CTCX annual cash flow from operations has changed by -$4.92 M (-143.48%)

What is Carmell Therapeutics quarterly cash flow from operations?

The current quarterly CFO of CTCX is -$1.40 M

What is the all time high quarterly CFO for Carmell Therapeutics?

Carmell Therapeutics all-time high quarterly cash flow from operations is -$194.90 K

What is Carmell Therapeutics quarterly CFO year-on-year change?

Over the past year, CTCX quarterly cash flow from operations has changed by $0.00 (0.00%)

What is Carmell Therapeutics TTM cash flow from operations?

The current TTM CFO of CTCX is -$7.03 M

What is the all time high TTM CFO for Carmell Therapeutics?

Carmell Therapeutics all-time high TTM cash flow from operations is -$194.90 K

What is Carmell Therapeutics TTM CFO year-on-year change?

Over the past year, CTCX TTM cash flow from operations has changed by $0.00 (0.00%)